Sep 28 2017
SEATTLE — Attorney General Bob Ferguson today filed a lawsuit accusing OxyContin maker Purdue Pharma of fueling the opioid epidemic in Washington state, embarking on a massive deceptive marketing campaign and convincing doctors and the public that their drugs are effective for treating chronic pain and have a low risk of addiction, contrary to overwhelming evidence. This deceptive marketing resulted in the deaths of Washingtonians and devastation to Washington families.
Jul 26 2017
Attorney General Bob Ferguson recovered nearly $750,000 in Medicaid reimbursement this week from pharmaceutical company Celgene Corporation for promoting medications to treat conditions they were not approved for, including certain types of cancer. The company is also accused of paying kickbacks to doctors for prescribing the medications and helping them change billing codes to ensure Medicaid would pay for their use.
May 30 2017
SEATTLE — Attorney General Bob Ferguson will hold a two-day summit in June on the opioid epidemic, convening law enforcement, medical professionals, prosecutors and public health experts.
Nov 17 2014
Attorney General’s Office presents argument defending rules requiring pharmacies to fill lawful prescriptions
PORTLAND, Ore. — This week, the Attorney General’s Office will defend rules requiring pharmacies to fill lawful prescriptions for time-sensitive medications.
May 20 2013
OLYMPIA—Washington has joined with other states and the federal government in a $500 million dollar settlement to resolve civil and criminal allegations against Ranbaxy, a generic pharmaceutical manufacturer based in Gurgaon, India. The company is alleged to have introduced adulterated—or tainted— drugs into interstate commerce, resulting in false or fraudulent claims being submitted to Washington’s Medicaid Program.
May 2 2013
Drug Manufacturer Amgen Agrees To Pay Medicaid Program Nearly $26 Million To Resolve Two False Claims Cases
Attorney General Bob Ferguson announced today Washington has joined a national settlement against the drug manufacturer Amgen, Inc., resolving allegations that Amgen violated certain state false claims acts by reporting inflated pricing data for its prescription drugs Aranesp, Enbrel, Epogen, Neulasta, Neupogen, and Sensipar.
Dec 19 2012
OLYMPIA – Washington State Attorney General Rob McKenna today announced that Washington joined with other states and the federal government to reach an agreement with Amgen, Inc., settling allegations that the drug-maker illegally marketed several drugs.
Dec 12 2012
State attorneys general reach deal over Zyvox and Lyrica SEATTLE – Washington State Attorney General Rob McKenna today announced that he and 33 other state attorneys general reached a $42.9 million settlement with Pfizer Inc. to resolve allegations that the company unlawfully promoted its drugs, Zyvox and Lyrica.
Aug 30 2012
SEATTLE – Washington State Attorney General Rob McKenna today announced that he and 36 other Attorneys General reached a record $181 million dollar settlement with Janssen Pharmaceuticals, Inc., a subsidiary of Johnson and Johnson. McKenna and his colleagues allege that Janssen improperly marketed the antipsychotic drugs Risperdal, Risperdal Consta, Risperdal M-Tab and Invega.
Jul 3 2012
GlaxoSmithKline settles drug marketing and pricing claims OLYMPIA –Attorney General Rob McKenna today announced Washington state’s share of the largest healthcare fraud settlement in U.S. history.